Robert Michael Dudley

Insider Reports History

Entity
Individual
Location
C/O Transcode Therapeutics, 6 Liberty Square #2382, Boston, MA
Signature
/s/ Thomas A. Fitzgerald, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Michael Dudley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Transcode Therapeutics, Inc. Chief Executive Officer, Director Common Stock 180K $91.9K $0.51 Sep 28, 2023 Direct

Insider Reports Filed by Robert Michael Dudley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNAZ Transcode Therapeutics, Inc. Sep 28, 2023 1 $50K 4 Oct 2, 2023 Chief Executive Officer, Director
RNAZ Transcode Therapeutics, Inc. Jun 20, 2023 2 $48.7K 4 Jun 22, 2023 Chief Executive Officer, Director
RNAZ Transcode Therapeutics, Inc. Jun 9, 2023 1 $52.4K 4/A Jun 14, 2023 Chief Executive Officer, Director
RNAZ Transcode Therapeutics, Inc. May 19, 2023 1 $0 4 May 19, 2023 Chief Executive Officer, Director
RNAZ Transcode Therapeutics, Inc. Dec 12, 2022 1 $0 4 Dec 14, 2022 Chief Executive Officer, Director, 10%+ Owner
RNAZ Transcode Therapeutics, Inc. Sep 14, 2022 1 $23K 4 Sep 16, 2022 Chief Executive Officer, Director, 10%+ Owner
RNAZ Transcode Therapeutics, Inc. May 27, 2022 2 $55.4K 4 Jun 1, 2022 Chief Executive Officer, Director, 10%+ Owner
RNAZ Transcode Therapeutics, Inc. Feb 1, 2022 1 $0 4 Feb 3, 2022 Chief Executive Officer, Director, 10%+ Owner
RNAZ Transcode Therapeutics, Inc. Jul 8, 2021 0 $0 3 Jul 8, 2021 Chief Executive Officer, Director, 10%+ Owner